JPS58208235A - 循環器系疾病治療剤 - Google Patents
循環器系疾病治療剤Info
- Publication number
- JPS58208235A JPS58208235A JP57091794A JP9179482A JPS58208235A JP S58208235 A JPS58208235 A JP S58208235A JP 57091794 A JP57091794 A JP 57091794A JP 9179482 A JP9179482 A JP 9179482A JP S58208235 A JPS58208235 A JP S58208235A
- Authority
- JP
- Japan
- Prior art keywords
- remedy
- citric acid
- therapeutic agent
- present
- papain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000024172 Cardiovascular disease Diseases 0.000 title description 5
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 48
- 239000000203 mixture Substances 0.000 claims abstract description 12
- 108090000526 Papain Proteins 0.000 claims abstract description 11
- 239000004365 Protease Substances 0.000 claims abstract description 11
- 229940055729 papain Drugs 0.000 claims abstract description 11
- 235000019834 papain Nutrition 0.000 claims abstract description 11
- 201000010099 disease Diseases 0.000 claims abstract description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 10
- 239000003814 drug Substances 0.000 claims description 40
- 229940124597 therapeutic agent Drugs 0.000 claims description 30
- 239000004480 active ingredient Substances 0.000 claims description 5
- 206010020772 Hypertension Diseases 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 11
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 10
- 201000005569 Gout Diseases 0.000 abstract description 6
- 239000007864 aqueous solution Substances 0.000 abstract description 5
- 239000000843 powder Substances 0.000 abstract description 5
- 208000014617 hemorrhoid Diseases 0.000 abstract description 4
- 239000008187 granular material Substances 0.000 abstract description 3
- 206010010774 Constipation Diseases 0.000 abstract description 2
- 239000002775 capsule Substances 0.000 abstract description 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 210000000748 cardiovascular system Anatomy 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 201000008383 nephritis Diseases 0.000 abstract 1
- 239000006187 pill Substances 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
- 210000002700 urine Anatomy 0.000 description 12
- 230000036772 blood pressure Effects 0.000 description 11
- 208000017169 kidney disease Diseases 0.000 description 8
- 229940079593 drug Drugs 0.000 description 7
- 238000009472 formulation Methods 0.000 description 7
- 238000011282 treatment Methods 0.000 description 7
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 3
- 206010028391 Musculoskeletal Pain Diseases 0.000 description 3
- 208000007613 Shoulder Pain Diseases 0.000 description 3
- 239000002220 antihypertensive agent Substances 0.000 description 3
- 229940127088 antihypertensive drug Drugs 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000035487 diastolic blood pressure Effects 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 230000035488 systolic blood pressure Effects 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- 230000001780 adrenocortical effect Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 201000005917 gastric ulcer Diseases 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000002747 voluntary effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 244000075850 Avena orientalis Species 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 240000006432 Carica papaya Species 0.000 description 1
- 235000009467 Carica papaya Nutrition 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000000157 blood function Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 229940031627 papain 50 mg Drugs 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- -1 vitamin C Natural products 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57091794A JPS58208235A (ja) | 1982-05-29 | 1982-05-29 | 循環器系疾病治療剤 |
| US06/497,029 US4477434A (en) | 1982-05-29 | 1983-05-23 | Medicinal compositions, foods and beverages having therapeutic effects on diseases of circulatory system and digestive system |
| GB08314542A GB2122488B (en) | 1982-05-29 | 1983-05-26 | Compositions containing papain and citric acid |
| DE19833319575 DE3319575A1 (de) | 1982-05-29 | 1983-05-30 | Therapeutisch wirksame zusammensetzungen, nahrungsmittel und getraenke |
| DE3348162A DE3348162C2 (enrdf_load_stackoverflow) | 1982-05-29 | 1983-05-30 | |
| DE3348163A DE3348163C2 (enrdf_load_stackoverflow) | 1982-05-29 | 1983-05-30 | |
| FR8308899A FR2527446B1 (fr) | 1982-05-29 | 1983-05-30 | Composition pharmaceutique comprenant une association de papaine et d'acide citrique, pouvant etre prise dans un aliment ou une boisson |
| DE3348164A DE3348164C2 (enrdf_load_stackoverflow) | 1982-05-29 | 1983-05-30 | |
| DE3348165A DE3348165C2 (enrdf_load_stackoverflow) | 1982-05-29 | 1983-05-30 | |
| DE3348153A DE3348153C2 (enrdf_load_stackoverflow) | 1982-05-29 | 1983-05-30 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57091794A JPS58208235A (ja) | 1982-05-29 | 1982-05-29 | 循環器系疾病治療剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS58208235A true JPS58208235A (ja) | 1983-12-03 |
| JPS64927B2 JPS64927B2 (enrdf_load_stackoverflow) | 1989-01-10 |
Family
ID=14036514
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP57091794A Granted JPS58208235A (ja) | 1982-05-29 | 1982-05-29 | 循環器系疾病治療剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS58208235A (enrdf_load_stackoverflow) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06172209A (ja) * | 1992-12-10 | 1994-06-21 | Reiko Kosaka | 動物の健康用組成物 |
| JP2002080357A (ja) * | 2000-09-05 | 2002-03-19 | Kao Corp | 高血圧症予防・改善・治療剤 |
-
1982
- 1982-05-29 JP JP57091794A patent/JPS58208235A/ja active Granted
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06172209A (ja) * | 1992-12-10 | 1994-06-21 | Reiko Kosaka | 動物の健康用組成物 |
| JP2002080357A (ja) * | 2000-09-05 | 2002-03-19 | Kao Corp | 高血圧症予防・改善・治療剤 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS64927B2 (enrdf_load_stackoverflow) | 1989-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8178498B1 (en) | Medicament and method of treating an organism with medicaments | |
| US4387093A (en) | Arthritis treatment | |
| RU2419449C1 (ru) | Средство для лечения больных лекарственным гепатитом | |
| JP2022133449A (ja) | レボドパ分割用量組成物および使用 | |
| CN107970231A (zh) | 一种治疗二型糖尿病的组合物 | |
| JPH01261334A (ja) | アンギオテンシン転換酵素阻害剤を有効成分とした医療用調剤及びその製造方法 | |
| JPS58208235A (ja) | 循環器系疾病治療剤 | |
| US6793935B2 (en) | Mineral supplement | |
| JP2022507646A (ja) | ブレイアコニチンａの用途 | |
| RU2152221C1 (ru) | Средство, обладающее гепатопротекторным, холестерино- и сахарорегулирующим действием | |
| JP3253878B2 (ja) | 鉄キレート化用製剤、その製剤の製法及び地中海貧血症の治療法 | |
| CN103181945B (zh) | 丝瓜子的用途 | |
| CN105343419A (zh) | 一种壮阳补肾中药丸及其制备方法 | |
| JP4610730B2 (ja) | カルシウム補給用の組成物 | |
| CN109908208A (zh) | 一种用于补肾壮阳的纯天然植物药组合物 | |
| KR102482128B1 (ko) | 관절염 치료효과가 증가된 새로운 메틸설포닐메탄(msm)을 함유하는 조성물 및 그 제조방법 | |
| US8703213B2 (en) | Anti-diabetic composition containing a plant extract of Englerina lecardii | |
| JPS60112720A (ja) | 肝臓疾患治療効果を有する薬剤 | |
| RU2122418C1 (ru) | Средство для лечения хронического гепатита неинфекционной этиологии | |
| KR20000074868A (ko) | 발기부전 치료용 조성물 (3) | |
| JPS5962526A (ja) | 人体の体質改善用無機質保健剤 | |
| JPH10114682A (ja) | グルコマンナン配合持効性内服用薬剤 | |
| KR20000074867A (ko) | 발기부전 치료용 조성물 (2) | |
| CN100560075C (zh) | 调节脂类代谢的药物 | |
| CN117338851A (zh) | 治疗糖尿病周围神经病变的中药组合物、制备方法和应用 |